← Browse by Condition
Medical Condition

pancreatectomy

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for pancreatectomy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pancreatectomy Clinical Trials

How many clinical trials are currently recruiting for pancreatectomy?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for pancreatectomy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pancreatectomy?
pancreatectomy research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pancreatectomy clinical trial?
Eligibility criteria for pancreatectomy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Oslo University Hospital 1 trial
Technische Universität Dresden 1 trial
Sahlgrenska University Hospital 1 trial

Recruiting Clinical Trials

NCT06944587
Recruiting
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
Enrollment
400 pts
Location
Norway
Sponsor
Oslo University Hospital
View Trial →
NCT06126601
Recruiting
Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety
Enrollment
150 pts
Location
Germany
Sponsor
Technische Universität Dresden
View Trial →
NCT06714604 Phase 3
Recruiting
Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC
Enrollment
432 pts
Location
Sweden
Sponsor
Sahlgrenska University Hospita...
View Trial →

Related Conditions

locally advanced pancreatic cancer (1) borderline resectable pancreatic cancer (1) chemotherapy effect (1) hyperamylasemia (1) pancreatitis acute (1) locally advanced pancreatic adenocarcinoma (1) borderline resectable pancreatic carcinoma (1) pancreas cancer (1) neoadjuvant chemotherapy (1) surgery (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology